Piracetam improves cognitive deficits caused by chronic cerebral hypoperfusion in rats

Author(s): He Z, Liao Y, Zheng M, Zeng FD, Guo LJ


Piracetam is the derivate of gamma-aminobutyric acid, which improves the cognition,memory,consciousness, and is widely applied in the clinical treatment of brain dysfunction. In the present experiments, we study the effects of piracetam on chronic cerebral hypoperfused rats and observe its influence on amino acids, synaptic plasticity in the Perforant path-CA3 pathway and apoptosis in vivo. Cerebral hypoperfusion for 30 days by occlusion of bilateral common carotid arteries induced marked amnesic effects along with neuron damage, including: (1) spatial learning and memory deficits shown by longer escape latency and shorter time spent in the target quadrant; (2) significant neuronal loss and nuclei condensation in the cortex and hippocampus especially in CA1 region; (3) lower induction rate of long term potentiation, overexpression of BAX and P53 protein, and lower content of excitatory and inhibitory amino acids in hippocampus. Oral administration of piracetam (600 mg/kg, once per day for 30 days) markedly improved the memory impairment, increased the amino acid content in hippocampus, and attenuated neuronal damage. The ability of piracetam to attenuate memory deficits and neuronal damage after hypoperfusion may be beneficial in cerebrovascular type dementia.

Similar Articles

Biology and chemistry of Ginkgo biloba

Author(s): Singh B, Kaur P, Gopichand, Singh RD, Ahuja PS

Memory expression is independent of memory labilization/reconsolidation

Author(s): Barreiro KA, Suárez LD, Lynch VM, Molina VA, Delorenzi A

Role of amygdala in drug memory

Author(s): Luo YX, Xue YX, Shen HW, Lu L

The impact of stroke on cognitive processing - a prospective event-related potential study

Author(s): Stahlhut L, Grotemeyer KH2, Husstedt IW1, Evers S3

Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo

Author(s): Szalma I, Kiss A, Kardos L, Horváth G, Nyitrai E, et al.

Evidence-based pharmacotherapy of Alzheimer's disease

Author(s): Evans JG, Wilcock G, Birks J

A new polysaccharide from leaf of Ginkgo biloba L

Author(s): Yang JF, Zhou DY, Liang ZY

Fingerprint profile of Ginkgo biloba nutritional supplements by LC/ESI-MS/MS

Author(s): Ding S, Dudley E, Plummer S, Tang J, Newton RP, et al.

Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on aging

Author(s): Cohen-Salmon C, Venault P, Martin B, Raffalli-Sébille MJ, Barkats M, et al.

The memory-enhancing effects of Ginseng and Ginkgo biloba in healthy volunteers

Author(s): Persson J, Bringlöv E, Nilsson LG, Nyberg L

Cognitive deterioration after venlafaxine overdose

Author(s): García-Cabeza I, de Blas MM, Epifanio MM, de Chávez MG

The antinociceptive effect of reversible monoamine oxidase-a inhibitors in a mouse neuropathic pain model

Author(s): Jardel G, Villarinho B, Kelly de V, Pinheirfrancielle D, Oliveira SM, Machado P, et al.